Begin typing your search...

Here is tech dose that keeps coronavirus at bay

Rural innovator from Telangana Chary imbibes his home-developed virus attenuation technology into Instashiled, an innovative medical device

image for illustrative purpose

Here is tech dose that keeps coronavirus at bay
X

5 April 2022 10:22 PM IST

Instashield is a plug and play device, with an effective coverage area of 5,000 sft and activates within 18 minutes of time, delivers the necessary signals to the electron emitters producing hypercharge high velocity electrons, which interact with the negative seeking s-protein of the corona family of viruses, thus, reducing infectivity and preventing air and surface borne transmission of the corona family of viruses

Hyderabad: Narishma Chary Mandaji, a rural innovator and also known for re-glowing the dead tubelights, after extensive research and experiments, has come up with a technology which is capable of killing all sorts of viruses including SARS-CoV, the coronavirus that causes Covid-19. His technology has been imbibed in Instashield, a break through innovative medical device, which uses first-of-its-kind virus attenuation technology that disables all kind of virus including SARS- CoV2 up to 99.9 per cent efficacy in an enclosed space, in air, and on the surfaces.

Chary said, "from the time SARS-CoV hit the world, I had been relentlessly working on building a technology that can fight this as well as other viruses. I am happy that my efforts have now taken the shape of a divine technology which is now finally going to be of use to mankind".

To his credit, Instashield innovator Chary has a lot of accolades and achievements with several patents. He has developed a formulation of re-glowing of filament less light without choke and starter. He also has developed a filament-less UV-C technology to neutralise and kill SARS-CoV2. With the same formula, he has developed electron-based negative ions technology and has IPR.

Instashield is a plug and play device that delivers the necessary signals to the electron emitters producing hypercharge high velocity electrons, which interact with the negative seeking s-protein of the corona family of viruses, thus, reducing infectivity and preventing air and surface borne transmission of the corona family of viruses. Its hyper charged cannons fire trillions (1-100 trillion electrons per second) of negatively charged ions, creating an electron cloud across closed spaces.

A single device has an effective coverage area starting from 5,000 sft and activates within 18 minutes of time. Instashield medical device is a patent technology backed by science and has received support from TSIC, ARCI and is an accredited lab tested and certified by CSIR-CCMB and other labs like EMTAC, Vimta, with CE for exports CDSCO, ISO 13485:2016, thus ensuring that it is 100 per cent safe for humans and environment. The brand is registered with MSME, Start-up India and GEM portal with Go green as a sustainable product.

Talking about Instashield, Hitesh M Patel, promoter & director, Instashield, says: "As per the WHO reports, SARS-CoV is pandemic and our lives will be with it forever. Hence, we need an alternative which has no side effects and has the maximum efficacy to kill any sort of virus. Thus, the technology created by Chary is a perfect fit in the current and coming times. Therefore, we thought of investing in the technology and giving it a form of a physical product, called Instashield that can be used at multiple places. We intend to take Instashield in the domestic as well as global markets".

"Since last couple of years, there has been a peak and low in the on-going coronavirus threat and is rapidly evolving mutations like Alpha, Gamma, Beta, Delta, Omicron, Delta Plus and recently the WHO has stated that the new Covid-19 variant dubbed Deltacron has been circulating in parts of Europe, USA, China, which is shortly expected to hit other parts of the world including India. And before it takes a serious turn, Instashield, a disruptive medical device, made in India, can save many lives across the globe," adds Patel.

SARS-CoV2 Coronavirus UV-C technology Narishma Chary Mandaji 
Next Story
Share it